Search Results for keywords:"confidential information"

The National Center for Complementary and Integrative Health announced a closed meeting on February 21, 2025, to evaluate grant applications related to early-phase clinical trials of natural products. This meeting, set to take place virtually, is closed to the public to protect confidential information, including trade secrets and personal data. The meeting will be led by Scientific Review Officer Jessica M. McKlveen, Ph.D., and will follow guidelines from the Federal Advisory Committee Act.

The National Institute of General Medical Sciences has announced several upcoming closed meetings as per section 1009 of the Federal Advisory Committee Act. These meetings will be held virtually and are scheduled between February 20 and March 24, 2025. The purpose of these meetings is to review and evaluate grant applications, which include discussions of confidential information. Various committees will focus on different areas such as the B2B & IRACDA Programs, Scientific Meetings & Conferences, and reviews of specific grant applications like the SuRE Award and the UE5 applications.

The Centers for Disease Control and Prevention (CDC) has announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting, scheduled for April 15-16, 2025, will take place via web conference from 10 a.m. to 5 p.m. EDT. During the meeting, the panel will review and evaluate grant applications related to research on the prevention of polysubstance-impaired driving. The meeting is closed to the public to protect confidential information and personal privacy.

The National Institute of Diabetes and Digestive and Kidney Diseases has announced a closed meeting on May 6, 2025, to review and evaluate grant applications. This meeting is closed to the public to protect confidential information and personal privacy. The meeting will be held virtually, with Lan Tian as the contact person for the event. The focus will be on assessing grant proposals related to urology and other relevant research areas.

The National Institute of Allergy and Infectious Diseases will have a closed meeting on February 3, 2025, from 1:00 p.m. to 3:00 p.m., held via video conference at their Rockville, MD location. The session is closed to the public because it involves discussing confidential contract proposals that contain trade secrets, commercial property, or personal information. The meeting's purpose is to review and evaluate development proposals for medical treatments addressing non-tuberculosis mycobacterial infections. For more details, Dr. Mario Cerritelli serves as the contact person for further inquiries.

The National Heart, Lung, and Blood Institute has announced two upcoming closed meetings in April 2025. These meetings are for reviewing and evaluating grant applications and will not be open to the public to protect confidential information, including trade secrets and personal details. The first meeting on April 14 will focus on the NHLBI Mentored Career Development K-Awards SEP, while the second on April 18 will discuss Transfusions in Preterm Neonates. Both meetings will be held virtually at the National Institutes of Health in Bethesda, Maryland.

The National Science Foundation (NSF) is holding a meeting for the Proposal Review Panel for Materials Research on May 19, 2025, as part of a virtual site visit to the Materials Research Science and Engineering Center at the University of Michigan. The meeting will be partly open to the public, with sessions including presentations, a poster session, and a closed executive session to discuss proprietary and confidential information. Anyone interested in attending the open sessions can request a virtual meeting link via email. The purpose of the meeting is to evaluate the program's performance and progress, and provide recommendations for improvement.

The Center for Scientific Review announced several upcoming closed meetings to review and evaluate grant applications. These sessions will be held virtually at the National Institutes of Health from March 11 to March 19, 2021. The meetings are closed to the public to protect confidential information and personal privacy associated with the applications. Key areas of focus include medical imaging, neurosciences, cardiovascular devices, and more.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting of their Special Emphasis Panel. The meeting, scheduled for April 30 to May 1, 2025, will review grant applications focused on strategies for eliminating HIV proteins. Because the discussions might involve confidential information or personal details, the meeting will not be open to the public. It will take place via video conference, and Stephen A. Gallo, Ph.D., will be the contact person for further inquiries.

The National Institute on Aging has announced a closed virtual meeting concerning clinical trials for managing early- and late-stage Alzheimer's Disease (AD). The meeting is scheduled for April 11, 2025, and will be held from 10:00 a.m. to 5:00 p.m. It will focus on reviewing and evaluating grant applications, and the discussions may involve confidential information. The contact for the meeting is Dr. Maurizio Grimaldi, whose contact details are provided for further inquiries.